| Literature DB >> 27857587 |
Rumi Shiba1, Mika Umeyama1, Sayaka Tsukasa1, Hironari Kamikubo1, Yoichi Yamazaki1, Mariko Yamaguchi1, Masahiro Iwakura2, Mikio Kataoka1.
Abstract
Decoding sequence information is equivalent to elucidating the design principles of proteins. For this purpose, we conducted systematic alanine insertion analysis to reveal the regions in the primary structure where the sequence continuity cannot be disrupted. We applied this method to dihydrofolate reductase (DHFR), and examined the effects of alanine insertion on structure and the enzymatic activity by solubility assay and trimethoprim resistance, respectively. We revealed that DHFR is composed of "Structure Elements", "Function Elements" and linkers connecting these elements. The "Elements" are defined as regions where the alanine insertion caused DHFR to become unstructured or inactive. Some "Structure Elements" overlap with "Function Elements", indicating that loss of structure leads to loss of function. However, other "Structure Elements" are not "Function Elements", in that alanine insertion mutants of these regions exhibit substrate- or inhibitor-induced folding. There are also some "Function Elements" which are not "Structure Elements"; alanine insertion into these elements deforms the catalytic site topology without the loss of tertiary structure. We hypothesize that these elements are involved essential interactions for structure formation and functional expression. The "Elements" are closely related to the module structure of DHFR. An "Element" belongs to a single module, and a single module is composed of some number of "Elements." We propose that properties of a module are determined by the "Elements" it contains. Systematic alanine insertion analysis is an effective and unique method for deriving the regions of a sequence that are essential for structure formation and functional expression.Entities:
Keywords: design principle of protein architecture; function element; module; sequence consecutivity; structure element
Year: 2011 PMID: 27857587 PMCID: PMC5036773 DOI: 10.2142/biophysics.7.1
Source DB: PubMed Journal: Biophysics (Nagoya-shi) ISSN: 1349-2942
Figure 1Examples of trimethoprim (TMP) resistance assay. The type of mutant contained in each transformant is shown in (a) and (d). Panels (b) and (e) show the colony formation of each transformant without TMP. Panels (c) and (f) indicate the colony formation of each transformant in media containing 1 μg/ml TMP.
Figure 7Comparison of the “Structure Elements” and “Function Elements” with some structural properties of DHFR. (a) “Function Elements”: a, L4-I5; b, D27-L28; c, F31-L36; d, D37-W47; e, L54-P55; f, G56-R57; g, K58-N59; h, M92-G96; i, G97-P105; j, Q108-H114; k, D122-T123; l, F125-P126.(b) “Structure Elements”: 1, I2-V10; 2, L28-E48; 3, I60-L62, 4, W74-I82; 5, E90-G96; 6, G97-P105; 7, K106-H114; 8, E120-G121; 9, D127-Y128; 10, E129-P130; 11, W133-S135; 12, Y151-E157. (c) Folding elements14: 1, S3-I14; 2, W30-L36; 3, V40-S49; 4, R57- S63; 5, E80-A83; 6, I91-L104; 7, A107-E118; 8, H124-F125; 9, V136-S138; 10, E154-I155. (d) α-helices: αB, P25-T35; αC, R44-I50; αD, V78-A84; αE, G97-F103. (e) β-sheets: βA, I2-L8; βB, V40-G43; βC, N59-L62; βD, T73-V75; βE, I91-G95; βF, K109-I115; βG, W133-H141; βH, Y151-R158. (f) Modules: M1, M1-V13; M2, I14-D27; M3, L28-G51; M4, R52-L62; M5, S63-G96; M6,G97-H124; M7, F125-R159. DHF-binding sites (pink arrow), NADPH-binding sites (black arrow) and early-folding sites32 (brown arrow) are also shown.
Figure 2Example of the solubility assay with fluorescent staining of SDS-PAGE. a, wild type, b, 1A2, c, 112A113 and d, 113A114. Lane 1, whole-cell; 2, precipitant; 3, supernatant. The left lane of each panel is the molecular weight marker, and the corresponding molecular weights are given.
Figure 3The results of the solubility assay. The ratio of the fluorescent intensity of the precipitant band to the sum of the intensities of the precipitant and supernatant bands is represented as a vertical bar at the mutation site. “Structure elements” are shaded in this figure.
Figure 4Solution structures of some alanine insertion mutants and the comparison with the solubility assay. (a) Far-UV CD spectra of wild type and alanine insertion mutants. Curves 1–6 represent wild type, 73A74, 85A86, 25A26, 47A48 and 74A75, respectively. DHFR concentration is 0.2mg/ml in 10mM potassium phosphate buffer C (pH 7.8) at 20°C. (b) Ellipticity at 203 nm is plotted against the precipitant ratio shown in Figure 4. The ellipticity is almost 0 for the folded DHFR, whereas it is large and negative for unstructured DHFR.
Figure 5The enzymatic activity of wild type and some alanine insertion mutants. Enzymatic activity was monitored by absorbance change at 340 nm. (a) The reaction curves of TMP-sensitive mutants. (b) The reaction curves of some TMP-resistant mutants. (c) The reaction curves of the other TMP-resistant mutants. The reaction solution contains 5.56nM DHFR, 50 μM DHF and 60 μM NADPH, in 10mM potassium phosphate buffer C (pH 7.8). Reactions were performed at 20°C.
Figure 6Mapping of the “Structure Elements” (a) and “Function Elements” (b) onto the structure of DHFR (PDB code: 1RX4). This figure was prepared using the program Weblab Viewer Pro18.